Doctor Evmorfia Aivalioti
National & Kapodistrian University of Athens Medical School, Athens (Greece)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Amyloid beta, a marker of vascular aging and cardiovascular disease, is associated with accelerated progression of renal dysfunction
Event: ESC Congress 2024
Topic: Epidemiology
Session: Secondary prevention: a multifactorial approach
Circulating Amyloid beta 1-40 is independently associated with statin treatment and LDL cholesterol reduction: a prospective cohort study
Event: ESC Congress 2024
Topic: Lipids
Session: Lipoproteins and cardiovascular risk
Circulating levels of amyloid-beta (1-40) peptide associate with cardiometabolic traits and risk for metabolic dysfunction-associated steatotic liver disease
Event: ESC Congress 2024
Topic: Metabolic Syndrome, Insulin, Insulin Resistance
Session: Liver metabolism and heart disease
